Although the revenue and EPS for Arcosa (ACA) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Arcosa (ACA) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.49 per share a year ago.
Arcosa (NYSE: ACA - Get Free Report) is anticipated to issue its Q1 2026 results after the market closes on Thursday, April 30th. Analysts expect the company to announce earnings of $0.46 per share and revenue of $639.50 million for the quarter. Parties may review the information on the company's upcoming Q1 2026 earning report for
Investors interested in stocks from the Building Products - Miscellaneous sector have probably already heard of Arcosa (ACA) and Installed Building Products (IBP). But which of these two stocks offers value investors a better bang for their buck right now?
Dynamic Technology Lab Private Ltd cut its stake in shares of Arcosa, Inc. (NYSE: ACA) by 80.7% during the undefined quarter, according to its most recent filing with the SEC. The institutional investor owned 2,685 shares of the company's stock after selling 11,195 shares during the period. Dynamic Technology Lab Private Ltd's holdings
Arcosa, Inc. (ACA) Q4 2025 Earnings Call Transcript
While the top- and bottom-line numbers for Arcosa (ACA) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Arcosa (ACA) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.46 per share a year ago.
Beyond analysts' top-and-bottom-line estimates for Arcosa (ACA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.
Arcosa has outperformed the S&P 500, driven by robust revenue, profit, and cash flow growth across all segments. ACA's Construction Products segment surged 45.7% YoY, boosted by the $1.2 billion Stavola acquisition, with segment revenue now 56% of total. Management guides for 2025 revenue of $2.86–$2.91 billion and EBITDA of $575–$585 million, reflecting continued organic and acquisition-driven growth.
Here is how Arcosa (ACA) and Argan (AGX) have performed compared to their sector so far this year.
Arcosa Inc. delivered a strong Q3 with a double beat, driven by robust 45% growth mainly in its key Construction Products segment. A healthy demand environment, along with a $1.3 billion backlog, provides clear visibility for sustained double-digit revenue growth into FY26. ACA's margins are expected to be driven by higher aggregate pricing, operational improvements, and accretive M&A.